FDA Inspection 1232428 — Haleon US Holdings LLC
The FDA completed an inspection of Haleon US Holdings LLC on Nov 22, 2024 in Berkeley Heights, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 22, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Berkeley Heights, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)